Subhash Arya, Ph.D., receives the 2024 Thermo Fisher Trainee Achievement Award

10:12 AM

Subhash Arya, Ph.D., Postdoc Fellow in the Parent Lab, has recently been selected as a recipient of the 2024 Thermo Fisher Trainee Achievement Award. Established in 1997, these awards recognize promising trainees in the field of immunology.
Congratulations, Subhash!
Featured News & Stories zoom screens with 7 different backgrounds and doctor silhouettes outlined in each
Health Lab
The doctor is in…. but what’s behind them?
A study reveals that what a doctor has behind them during a telehealth visit can make a difference in how the patient feels about them and their care.
 dad on left, mom sitting next to son all talking smiling
Health Lab
How you can teach your kids to stay safe in the sun
A melanoma survivor shares facts and tips about preventing all types of skin cancer.
 Mike Holinstat
Department News
Mike Holinstat, Ph.D. has article posted in CELL
Mike Holinstat, Ph.D., recently co-authored an article, "An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis", that was posted in CELL.
 left mom and son holding hands in blue long sleeves with medals on after run and on right young man standing in red sleeves top with sunglasses on sunny smiling
Health Lab
Despite tremendous hurdles, a young man is thankful for “the ultimate gift of life”
Young man with cystic fibrosis gets organ donation that changes his life
 blue gloves in hospital hanging IV bag
Health Lab
Commonly used antibiotic brings more complications, death in the sickest patients
In emergency rooms and intensive care units across the country, clinicians make split-second decisions about which antibiotics to give a patient when a life threatening infection is suspected. Now, a study reveals that these decisions may have unintended consequences for patient outcomes.
 mushrooms in a microscope
Health Lab
How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic pain
Recent developments represent a dramatic change from long standing federal policy around these substances that has historically criminalized their use and blocked or delayed research efforts into their therapeutic potential.